SynthesisPloS one2018

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.

Elmira Agah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.